Recombinant soluble IFN receptor (sIFNAR2) exhibits intrinsic therapeutic efficacy in a murine model of Multiple Sclerosis.

Suardíaz M, Clemente D, Marin-Bañasco C, Orpez T, Guerrero-Hurtado I, Pavía P, Pinto-Medel MJ, de Castro F, Leyva L, Fernández O, et al.